Correspondence 0001193125-24-240541 from Oaktree Acquisition Corp. III Life Sciences (OACC, OACCU) (CIK 0002029769) (OACC)
Oaktree Acquisition Corp. III Life Sciences (OACC, OACCU) (CIK 0002029769)
Date: Oct. 21, 2024 · CIK: 0002029769 · Accession: 0001193125-24-240541
AI Filing Summary & Sentiment
File numbers found in text: 333-282508
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Re: Oaktree Acquisition Corp. III Life Sciences Registration Statement on Form S-1, as amended Initially Filed October 4, 2024 File No. 333-282508
Dear Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for themselves and the other several underwriters, hereby joins in the request of Oaktree Acquisition Corp. III Life Sciences that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4.30 p.m. Eastern time on October 23, 2024, or as soon thereafter as practicable.
Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that approximately 900 copies of the Preliminary Prospectus dated October 18, 2024 are expected to be distributed to prospective underwriters and dealers, institutional investors, retail investors and others.
The undersigned advises that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
* * *
[Signature Page Follows]
Very truly yours,
JEFFERIES LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP Jefferies LLC 520 Madison Avenue New York, New York 10022 Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 UBS Securities LLC 1285 Avenue of the Americas New York, New York 10019 October 21, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn.: Stacie Gorman Re: Oaktree Acquisition Corp. III Life Sciences Registration Statement on Form S-1, as amended Initially Filed October 4, 2024 File No. 333-282508 Dear Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for themselves and the other several underwriters, hereby joins in the request of Oaktree Acquisition Corp. III Life Sciences that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4.30 p.m. Eastern time on October 23, 2024, or as soon thereafter as practicable. Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that approximately 900 copies of the Preliminary Prospectus dated October 18, 2024 are expected to be distributed to prospective underwriters and dealers, institutional investors, retail investors and others. The undersigned advises that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. * * * [Signature Page Follows] Very truly yours, JEFFERIES LLC By: /s/ Tina Pappas Name: Tina Pappas Title: Managing Director CITIGROUP GLOBAL MARKETS INC. By: /s/ Raghav Chadha Name: Raghav Chadha Title: Director UBS SECURITIES LLC By: /s/ Mehul Choudhary Name: Mehul Choudhary Title: Director By: /s/ Ryan Obuchowski Name: Ryan Obuchowski Title: Associate Director As Representatives of the several underwriters [Signature Page to Underwriters’ Acceleration Request Letter]